Skip to content
Search

Latest Stories

FEATURE: Helping beat the winter blues

As pharmacy teams brace themselves for a second wave of Covid-19 and a season of cold and flu, superintendent pharmacist Sobha Sharma Kandel offers some expert advice

Winter is imminent and with dropping temperatures viruses are bound to be more prevalent, exacerbating health problems among the vulnerable and immunocompromised patients. This can cause serious complications, and therefore, it’s important to know the symptoms, methods to manage them and when to refer.


A healthy person can usually manage the illnesses with over-the counter medication. Colds, flu and Covid-19 are caused by different viruses. As some of their symptoms overlap, it may be hard to tell the difference. However, some key differences are shown in the following figure.

It is also possible to suffer from cold/flu and Covid-19 simultaneously, which can complicate matters. As per NHS guidelines, anyone with fever, cough, loss/change in sense of taste and/or smell has to self-isolate and request a Covid test.

Pharmacy Advice

The pharmacy team should advise patients with symptoms to take rest, ensure adequate hydration and take balanced nutrition. Supplements such as Vitamin C, Vitamin D and zinc can also help to boost the immune system and can be recommended.

Pharmacy teams can recommend analgesics such as paracetamol or ibuprofen to help relieve associated muscle pain and headaches, and lower temperature. Paracetamol has an analgesic (painkilling), as well as an antipyretic effect (works on the brain to bring down a fever). It is a safe drug. However, an overdose can be dangerous, and therefore, the pharmacy team should check if the patient is on any other medication that has paracetamol.

Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen also inhibits prostaglandins. It has anti-inflammatory, analgesic and antipyretic activity.

The main problem with NSAIDs is their irritant effect on the gastrointestinal system. It should be taken with food and should not be taken by patients with a history of stomach ulcer, indigestion, asthma or kidney disease.

Oral or nasal decongestants reduce nasal swelling and may help ease breathing but should not be used for longer than seven days because they can aggravate congestion. They should also not be used at night as they can inhibit sleep.

Nice guideline suggests honey could be effective in reducing acute coughs except for children under 12 months of age. Other remedies include the herbal remedy pelargonium, and cough medicines containing either guaifenesin or antitussive dextromethorphan (for 12 years and above).

Lozenges, anaesthetic spray or anti-inflammatory spray can be used. Gargling with antiseptic mouth rinse or salt water (not for children) and taking warm drinks with honey can help. Severe sore throat pain and difficulty in swallowing must be referred to a GP as tonsillitis and antibiotics may be needed.

Advice for children

Ensure adequate hydration and rest. Products to recommend: A thermometer to monitor temperature, saline nasal drops or sprays for nasal congestion, analgesics like paracetamol, ibuprofen, glycerin-based cough syrups, topical rubs, and humidifier in the room.

The majority of cold and flu symptoms will clear up in four to five days. However, complete recovery from a cold or flu can take between 10-14 days. Post viral fatigue can also last a couple of weeks. Colds are much more common than flu and less severe.

Many OTC cold and cough medicines contain combinations of analgesics, decongestants and cough suppressants to relieve multiple symptoms; therefore, the pharmacy team needs to advice patients to not take any other remedies with same ingredients to prevent overdose.

Pharmacists and their staff have an essential role to play as they are the first port of call for patients. They should provide reassurance, give advice and recommend safe products and have an important function of signposting or referring patients if and when needed.

Sobha Sharma Kandel is superintendent pharmacist of Neem Tree Pharmacy in London.

This feature also appears in the print edition of Pharmacy Business/Oct 2020. 

More For You

Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less
Unlocking the potential of technology in pharmacy

Harry McQuillan, chairman, Numark

Technology in pharmacy goes beyond operational improvements

Community pharmacies are expected to take on greater responsibilities to ease pressure on other healthcare services and meet growing patient demands. However, despite their expanding role, they continue to lack adequate financial support.

“While funding negotiations continue, one thing remains clear, technology is key to ensuring pharmacy can thrive in a rapidly evolving healthcare landscape,” said Harry McQuillan, chairman of Numark.

Keep ReadingShow less